Sanofi ($SNY) R&D chief Elias Zerhouni aims to practice "true translational medicine" to amp up drug-development productivity at the French drugmaker. Report
Sanofi ($SNY) R&D chief Elias Zerhouni aims to practice "true translational medicine" to amp up drug-development productivity at the French drugmaker. Report